Trial Profile
ASP7991 Clinical Pharmacological Study -Examination of Pharmacokinetics and Pharmacodynamics in Chronic Kidney Disease Patients Undergoing Hemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 7991 (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 15 Apr 2014 New trial record